{"id":"https://openalex.org/W29655103","doi":null,"title":"[Personal experience with 200mg of micronized fenofibrate (Lipanthyl 200 M) in the treatment of primary dyslipidemias].","display_name":"[Personal experience with 200mg of micronized fenofibrate (Lipanthyl 200 M) in the treatment of primary dyslipidemias].","publication_year":1996,"publication_date":"1996-04-01","ids":{"openalex":"https://openalex.org/W29655103","mag":"29655103","pmid":"https://pubmed.ncbi.nlm.nih.gov/8693709"},"language":"cs","primary_location":{"id":"pmid:8693709","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8693709","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vnitrni lekarstvi","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084174709","display_name":"H Vaverkov\u00e1","orcid":"https://orcid.org/0000-0001-5249-8136","observed_orcids":["https://orcid.org/0000-0001-5249-8136"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Vaverkov\u00e1","raw_affiliation_strings":["III. Intern\u00ed klinika FN, Olomouc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"III. Intern\u00ed klinika FN, Olomouc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027400640","display_name":"Dalibor Novotn\u00fd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Novotn\u00fd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"L Ficker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Ficker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00302608,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"4","first_page":"239","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":0.9779999852180481},{"id":"https://openalex.org/keywords/primary-dyslipidemia","display_name":"primary dyslipidemia","score":0.9079999923706055},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.7080000042915344},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.7630000114440918},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.8209999799728394},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9539999961853027},{"id":"https://openalex.org/keywords/apolipoprotein-a-i","display_name":"apolipoprotein A-I","score":0.8399999737739563},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.9369999766349792},{"id":"https://openalex.org/keywords/uric-acid","display_name":"uric acid","score":0.921999990940094},{"id":"https://openalex.org/keywords/fibrinogen","display_name":"fibrinogen","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lipoprotein-a","display_name":"lipoprotein(a)","score":0.9449999928474426},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.7379999756813049},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.6980000138282776},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.8054439425468445},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.6166380643844604},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.5866782665252686},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5661250948905945},{"id":"https://openalex.org/C2779036427","wikidata":"https://www.wikidata.org/wiki/Q381899","display_name":"Fibrinogen","level":2,"score":0.5380257368087769},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5132472515106201},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4993407726287842},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.4746844470500946},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.46876996755599976},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.44741126894950867},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4323498606681824},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37162378430366516}],"mesh":[{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004304","descriptor_name":"Dosage Forms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:8693709","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8693709","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vnitrni lekarstvi","raw_type":"Clinical Trial"},{"id":"mag:29655103","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8693709","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1979429480","https://openalex.org/W2004809711","https://openalex.org/W2017316301","https://openalex.org/W2307866871","https://openalex.org/W1984332219","https://openalex.org/W2322437251","https://openalex.org/W2259233223","https://openalex.org/W2173828297","https://openalex.org/W1976770880","https://openalex.org/W2167567374","https://openalex.org/W2334573654","https://openalex.org/W2076522940","https://openalex.org/W2753879044","https://openalex.org/W2022041605","https://openalex.org/W2006226539","https://openalex.org/W2560702716","https://openalex.org/W1523704017","https://openalex.org/W261228946","https://openalex.org/W2031324202","https://openalex.org/W2263492392","https://openalex.org/W1987107175","https://openalex.org/W2095649629","https://openalex.org/W2115938949","https://openalex.org/W2322346801","https://openalex.org/W2073925793","https://openalex.org/W1694693019","https://openalex.org/W2055664397","https://openalex.org/W1994835533","https://openalex.org/W2562633815","https://openalex.org/W2789271970","https://openalex.org/W2101565368","https://openalex.org/W2062118486","https://openalex.org/W2307599527","https://openalex.org/W2024343903"],"related_works":["https://openalex.org/W2414217957","https://openalex.org/W2409609866","https://openalex.org/W2049554168","https://openalex.org/W2034600674","https://openalex.org/W2029899407","https://openalex.org/W2058332374","https://openalex.org/W1986438251","https://openalex.org/W2327573495","https://openalex.org/W2385956122","https://openalex.org/W2036290445"],"abstract_inverted_index":{"Micronized":[0,201],"phenofibrate":[1,202],"200":[2,204],"mg":[3],"was":[4,17,47,82,86,153,192],"administered":[5,261],"in":[6,53,71,76,180,224,262],"clinical":[7],"trial":[8],"to":[9,89,148,207,250],"30":[10,122],"patients":[11],"with":[12,21,25,30,240],"dyslipidaemia.":[13],"Their":[14],"average":[15],"age":[16],"51.9":[18],"years":[19],"(10":[20],"type":[22,26,181,236],"2a,":[23],"12":[24,36],"2b":[27],"and":[28,33,59,67,74,79,98,107,117,123,161,196,217,257],"8":[29],"types":[31,72,77,229],"4":[32,78],"5).":[34],"After":[35],"weeks":[37],"of":[38,42,127,157,227,230,235],"treatment":[39,226],"significant":[40,155],"improvement":[41],"the":[43,128,133,136,139,142,145,158,213,225,233,243,252],"whole":[44],"lipid":[45,215],"profile":[46,216],"achieved.":[48],"The":[49,100,109,125,183,190],"total":[50],"cholesterol":[51,63],"declined":[52,64,94,113,168,172],"different":[54],"sub-groups":[55],"by":[56,65,95,104,114,121,174],"16,":[57,105],"17":[58],"20%":[60],"resp.":[61],"LDL":[62],"20":[66],"18":[68],"per":[69],"cent":[70],"2a":[73],"2b,":[75],"5":[80],"it":[81,248,258],"not":[83,87,187],"assessed":[84],"(it":[85],"possible":[88,249],"use":[90],"Friedewald's":[91],"equation).":[92],"Triglycerides":[93],"39,":[96],"45":[97],"75%.":[99],"HDL":[101],"concentration":[102,185],"increased":[103],"27":[106],"25%.":[108],"atherogenic":[110],"indexes":[111],"TCh/HDL-Ch":[112],"28,":[115],"36":[116],"32%.":[118],"LDL-Ch/HDL-Ch":[119],"dropped":[120,177],"34%.":[124],"extent":[126],"hypolipidaemic":[129],"effect":[130,211],"depended":[131],"on":[132,212],"baseline":[134,140],"value:":[135],"more":[137,143],"pathological":[138],"value,":[141],"marked":[144],"improvement.":[146],"As":[147,238],"other":[149,218],"investigated":[150],"indicators":[151],"there":[152],"a":[154,263],"rise":[156],"apolipoprotein":[159],"AI":[160,163],"Lp":[162],"particle":[164],"concentration.":[165],"Apoprotein":[166],"B":[167],"insignificantly.":[169],"Uric":[170],"acid":[171],"significantly":[173,178],"28%.":[175],"Fibrinogen":[176],"only":[179],"2a.":[182],"lipoprotein(a)":[184],"did":[186],"change":[188],"significantly.":[189],"drug":[191],"very":[193],"well":[194],"tolerated":[195],"undesirable":[197],"effects":[198],"were":[199],"minimal.":[200],"(Lipanthyl":[203],"M)":[205],"due":[206],"its":[208],"comprehensive":[209],"favourable":[210],"entire":[214],"risk":[219],"factors":[220],"can":[221,259],"prove":[222],"useful":[223],"all":[228],"dyslipidaemias":[231],"(with":[232],"exception":[234],"I).":[237],"compared":[239],"Lipanthyl":[241],"100,":[242],"better":[244],"pharmacokinetic":[245],"properties":[246],"make":[247],"reduce":[251],"dose":[253],"from":[254],"300":[255],"mg/day":[256],"be":[260],"single":[264],"daily":[265],"dose.":[266]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}